Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure.

作者信息

Locatelli Francesco, Aljama Pedro, Bárány Peter, Canaud Bernard, Carrera Fernando, Eckardt Kai-Uwe, Hörl Walter H, Macdougal Iain C, Macleod Alison, Wiecek Andrzej, Cameron Stewart

出版信息

Nephrol Dial Transplant. 2004 May;19 Suppl 2:ii1-47. doi: 10.1093/ndt/gfh1032.

DOI:10.1093/ndt/gfh1032

PMID:15206425

Abstract

摘要

相似文献

[1]

Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure.

Nephrol Dial Transplant. 2004-5

[2]

[Stability of hemoglobin levels: an indispensible paradigm change in medical management].

Nephrol Ther. 2011-2

[3]

Variations in erythropoiesis and serum ferritin during erythropoietin therapy for anaemia of end-stage renal disease.

Acta Haematol. 1993

[4]

II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults.

Am J Kidney Dis. 2006-5

[5]

Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly.

J Am Med Dir Assoc. 2006-11

[6]

[Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].

Rev Med Chil. 1990-6

[7]

Should the hematocrit (hemoglobin) be normalized in Pre-ESRD or dialysis patients? Yes!

Blood Purif. 2001

[8]

Effects of proactive iron and erythropoiesis-stimulating agent protocol implementation on achieving clinical guideline targets for anaemia in a satellite haemodialysis patient cohort.

Nephrology (Carlton). 2010-4

[9]

Should the hematocrit be normalized in dialysis and in pre-ESRD patients?

Blood Purif. 2001

[10]

Statement on the clinical use of recombinant erythropoietin in anemia of end-stage renal disease. Ad Hoc Committee for the National Kidney Foundation.

Am J Kidney Dis. 1989-9

引用本文的文献

[1]

Randomized, Positive-Controlled Study on the Efficacy and Safety of Oral Polysaccharide-Iron Complex Therapy in Patients on Hemodialysis.

Kidney Int Rep. 2025-3-17

[2]

ENDOCRINE AND GROWTH ABNORMALITIES IN CHILDREN WITH KIDNEY FAILURE ON MAINTENANCE HEMODIALYSIS - EXPERIENCE OF A SINGLE CENTER FROM WESTERN ROMANIA.

Acta Endocrinol (Buchar). 2024

[3]

Long-term safety and effectiveness of roxadustat in Chinese patients with chronic kidney disease-associated anemia: The ROXSTAR registry.

Chin Med J (Engl). 2025-6-20

[4]

UK kidney association clinical practice guideline: update of anaemia of chronic kidney disease.

BMC Nephrol. 2025-4-16

[5]

Safety and efficacy of pemetrexed for patients with non-small cell lung cancer in the setting of renal impairment: a retrospective study.

BMC Cancer. 2025-3-4

[6]

Prevalence and Treatment Patterns of Anaemia in Individuals With Chronic Kidney Disease Across Asia: A Systematic Review and Meta-Analysis.

Nephrology (Carlton). 2025-2

[7]

N-terminal pro-brain natriuretic peptide and cardiorenal outcome in patients with anaemia in chronic kidney disease.

ESC Heart Fail. 2025-4

[8]

Hypoxia-inducible factor activators: a novel class of oral drugs for the treatment of anemia of chronic kidney disease.

Hematology Am Soc Hematol Educ Program. 2024-12-6

[9]

Multi-modal characterisation of early-stage, subclinical cardiac deterioration in patients with type 2 diabetes.

Cardiovasc Diabetol. 2024-10-19

[10]

Evaluating the associations between compliance with CKD guideline component metrics and renal outcomes.

Sci Rep. 2024-5-20

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献